Contract facts
NONERADIOPHARMACEUTICALS EO 14398 is a federal NONE award for Network Contract Office 19 (36C259) held by University of Oklahoma. Estimated value —. Related solicitation 36C25922Q0711.
Incumbent footprint
Public recordUniversity of Oklahoma — $17.3M obligated across 67 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25923D0003?
36C25923D0003 (Radiopharmaceuticals EO 14398) is a Network Contract Office 19 (36C259) award with an estimated value of —, currently held by University of Oklahoma. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C259-23-D-0003?
36C259-23-D-0003 is the dashed form of PIID 36C25923D0003 (Radiopharmaceuticals EO 14398), held by University of Oklahoma. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25923D0003?
Network Contract Office 19 (36C259) awarded 36C25923D0003 to University of Oklahoma.
Who is the incumbent on 36C25923D0003?
University of Oklahoma is the incumbent with $17.3M across 67 related awards in SCOUT’s public footprint.
When does University of Oklahoma’s 36C25923D0003 come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.